Cargando…

Programmed cell death-1 blockade in combination with stereotactic radiation in an orthotopic mouse model of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Friedman, David, Baird, Jason, Young, Kristina, Cottam, Benjamin, Jutric, Zeljka, Crittenden, Marka, Gough, Michael, Newell, Pippa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649310/ http://dx.doi.org/10.1186/2051-1426-3-S2-P369

Ejemplares similares

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
por: Baird, Jason, et al.
Publicado: (2015)

Improved efficacy of radiation in combination with TGFβ inhibition in a colorectal cancer mouse model
por: Young, Kristina H, et al.
Publicado: (2013)

Immune consequences of CT-guided radiation therapy of mouse mammary tumors
por: Gough, Michael J, et al.
Publicado: (2013)

Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
por: Crittenden, Marka R., et al.
Publicado: (2012)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
por: Young, Kristina H., et al.
Publicado: (2016)

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
por: Crocenzi, Todd, et al.
Publicado: (2016)

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma
por: Gunderson, Andrew J., et al.
Publicado: (2019)

Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
por: Friedman, David J, et al.
Publicado: (2014)

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
por: Crittenden, Marka R., et al.
Publicado: (2016)

The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
por: Crittenden, Marka R., et al.
Publicado: (2013)

The Impact of the Myeloid Response to Radiation Therapy
por: Gough, Michael J., et al.
Publicado: (2013)

Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer
por: Bernard, Brady, et al.
Publicado: (2020)

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

The paradox of radiation and T cells in tumors
por: Gough, Michael J., et al.
Publicado: (2022)

ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control
por: Blair, Tiffany, et al.
Publicado: (2022)

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
por: Crittenden, Marka R., et al.
Publicado: (2018)

STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2017)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

The TAM family as a therapeutic target in combination with radiation therapy
por: Tormoen, Garth W., et al.
Publicado: (2017)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)

NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
por: Yahyanejad, Sanaz, et al.
Publicado: (2016)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

Radiation and immunotherapy: Renewed allies in the war on cancer
por: Seung, Steven K., et al.
Publicado: (2012)

Myeloid MyD88 restricts CD8(+) T cell response to radiation therapy in pancreatic cancer
por: Medler, Terry R., et al.
Publicado: (2023)

Defining Immunogenic and Radioimmunogenic Tumors
por: Medler, Terry R., et al.
Publicado: (2021)

Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement
por: Chen, Emily, et al.
Publicado: (2018)

Explant Modeling of the Immune Environment of Head and Neck Cancer
por: Sharon, Shay, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
por: Twyman, Christina, et al.
Publicado: (2013)

The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors
por: Blair, Tiffany C., et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
por: Pérez-Romasanta, Luis A., et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ql0cig8i0c5mm50jtn9ndl9str